Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small- Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02431260
What this trial is testing

An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 69
Testing effectiveness (Phase 2)Study completedNCT00043823
What this trial is testing

Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Ended earlyNCT06094296
What this trial is testing

BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC
Bristol-Myers Squibb 1
Testing effectiveness (Phase 2)Looking for participantsNCT04787042
What this trial is testing

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Who this might be right for
CancerSolid TumorMelanoma+6 more
Simcha IL-18, Inc. 316
Early research (Phase 1)Study completedNCT01034748
What this trial is testing

A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 6
Early research (Phase 1)Study completedNCT02225405
What this trial is testing

Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer

Who this might be right for
Stage IB Non-Small Cell Lung Carcinoma AJCC v7Stage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7+2 more
M.D. Anderson Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00405951
What this trial is testing

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Gemin X 47
Early research (Phase 1)Study completedNCT00002519
What this trial is testing

Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT06467500
What this trial is testing

A Prospective, Open-label, Single-center, Single-arm Phase II Clinical Study of Cadonilimab (AK104) Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed Immunotherapy

Who this might be right for
Non-small Cell Lung Cancer
Xin-Hua Xu 48
Testing effectiveness (Phase 2)UnknownNCT01980472
What this trial is testing

Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Grupo de Investigación y Divulgación Oncológica 50
Early research (Phase 1)Active Not RecruitingNCT07009457
What this trial is testing

A Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer

Who this might be right for
Widespread Small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 24
Early research (Phase 1)UnknownNCT05555212
What this trial is testing

To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation

Who this might be right for
Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 72
Not applicableStudy completedNCT04887519
What this trial is testing

Brigatinib to Treat Adults With Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell LungAnaplastic Lymphoma Kinase
Takeda 39
Early research (Phase 1)Ended earlyNCT01288430
What this trial is testing

DS-2248 in Participants With Advanced Solid Tumors

Who this might be right for
Solid TumorsNon-small Cell Lung Carcinoma
Daiichi Sankyo 60
Not applicableStudy completedNCT03782207
What this trial is testing

A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

Who this might be right for
Urothelial CarcinomaNon-Small Cell Lung CancerSmall Cell Lung Cancer+1 more
Hoffmann-La Roche 2,756
Not applicableUnknownNCT04878692
What this trial is testing

Evaluation of a Cosmetic Product to Preserve Skin Conditions When Using Anti-EGFR Cancer Therapies

Who this might be right for
Carcinoma, Non-Small-Cell LungColorectal NeoplasmsHead and Neck Neoplasms
Hospices Civils de Lyon 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT04958811
What this trial is testing

Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC

Who this might be right for
Non-squamous Non-small-cell Lung Cancer
Georgetown University 29
Testing effectiveness (Phase 2)UnknownNCT03799094
What this trial is testing

Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Clifford Hospital, Guangzhou, China 150
Large-scale testing (Phase 3)UnknownNCT04968002
What this trial is testing

Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy

Who this might be right for
Non-small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Early research (Phase 1)Ended earlyNCT00424775
What this trial is testing

Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066)

Who this might be right for
Neoplasms
Merck Sharp & Dohme LLC 3
Next Page